{"id":"W2082045121","doi":"10.1111/epi.12894","title":"Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial‐onset seizures: Results of a phase <scp>III</scp>, double‐blind, randomized, placebo‐controlled trial","year":2014,"lang":"en","type":"article","venue":"Epilepsia","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Sunovion","keywords":"Placebo; Adverse effect; Medicine; partial seizures; Randomized controlled trial; Clinical endpoint; Double blind; Anesthesia; Adjunctive treatment; Clinical trial; Incidence (geometry); Internal medicine; Epilepsy; Psychiatry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003293296,0.0006540292,0.00368113,0.0005681152,0.0001155612,0.0000478845,0.0002574679,0.0002535228,0.00007003692],"category_scores_gemma":[0.003909427,0.0003938965,0.0006698183,0.0006201562,0.0004099926,0.0001750399,0.00005835673,0.000572017,0.00006442364],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000149331,"about_ca_system_score_gemma":0.0005277125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003957688,"about_ca_topic_score_gemma":0.00009823122,"domain_scores_codex":[0.9936689,0.001536494,0.001699737,0.0008725491,0.001271982,0.0009503075],"domain_scores_gemma":[0.9930446,0.00408106,0.0008530266,0.0009570603,0.0005598956,0.0005043358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9839844,0.006449324,0.002109737,0.0000295099,0.002610029,0.00009252124,0.001011433,0.00005208516,0.00004698162,0.0001838614,0.001175006,0.00225514],"study_design_scores_gemma":[0.9709007,0.02349385,0.001138663,0.0002057855,0.0005755238,0.000006929703,0.0001016983,0.001093763,0.001230773,0.0002319377,0.0008462721,0.0001740967],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9706712,0.0003642908,0.0001266034,0.0005856035,0.0002175303,0.02228811,0.00008890762,0.00008323395,0.005574562],"genre_scores_gemma":[0.9927782,0.0002834037,0.0002073833,0.0002737638,0.000285073,0.003942697,0.0005298096,0.00007567809,0.001623942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02210709,"threshold_uncertainty_score":0.9998513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01791461518351743,"score_gpt":0.3060329943284735,"score_spread":0.288118379144956,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}